EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Normoferritinemic Versus Hyperferritinemic Inflammation in Patients Admitted to the Department of Internal Medicine

Saar Beit Yaakov iD, Ori Argov, Ori Rogowski, Chen Klechevski, Saritte Perlman, Moshe Shtark, Tomer Ziv Baran iD, Shlomo Berliner, Asaf Wasserman

Journal of Clinical Medicine · 31.03.2026 · 15 (7) · 2646

DOI: 10.3390/jcm15072646 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 31.03.2026. Verfasst von Saar Beit Yaakov und 8 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine "C" Department, Tel Aviv Sourasky University Medical Center, Tel Aviv 6423906, Israel. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dalya & Arye Prashkovsky grant for medical research, Dalya & Arye Prashkovsky.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Screening patients admitted to internal medicine for hyperferritinemia might reveal a dichotomy between normoferritinemic inflammation and hyperferritinemic inflammation phenotypes, opening new research into innate immunity activation during acute inflammation.

Methods

We identified 4514 consecutive patients screened for CRP and ferritin on admission. Patients with CRP ≤ 150 mg/L were excluded. We selected 100 patients with the lowest (normoferritinemic inflammation) and 100 with the highest (hyperferritinemic inflammation) ferritin concentrations. Sub-analysis of 39 CRP-matched pairs (±15 mg/L) and multivariable logistic regression—adjusting for age, sex, sepsis, malignancy, CRP, and comorbidities—were performed.

Results

Groups did not differ significantly by age (p = 0.068) or sex (p = 0.319). Mortality was significantly higher in the hyperferritinemic inflammation group (41% vs. 7%, p < 0.001), a trend maintained in non-malignant (31.1% vs. 6.5%, p < 0.001) and CRP-matched (25.6% vs. 2.6%, p = 0.012) subgroups. Multivariable regression confirmed hyperferritinemic inflammation as a significant independent predictor of mortality (OR 3.726; 95% CI 1.304–10.647; p = 0.014), even after adjusting for the Charlson Comorbidity Index.

Conclusions

Significant inflammation accompanied by hyperferritinemic inflammation is associated with elevated mortality compared to normoferritinemic inflammation, suggesting a dichotomous divergence of the inflammatory response.

Schlagwörter

Stichwörter der Autor:innen

C-reactive proteinhyperferritinemiainflammationmacrophage activationnormoferritinemiaprognostic biomarkersepsis

Autor:innen und Institutionen

  • Internal Medicine "C" Department, Tel Aviv Sourasky University Medical Center, Tel Aviv 6423906, Israel.
  • Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Department of Health Policy and Management, Faculty of Health Sciences, Ben Gurion University of the Negev, Beersheva 8410501, Israel.
  • Division of clinical Laboratories, Tel-Aviv Sourasky University Medical Center, Tel Aviv 6423906, Israel.
  • Department of Epidemiology and Preventive Medicine, School of Public Health, Gray Faculty of Medical & Health Science, Tel Aviv University, Tel Aviv 6139001, Israel.
  • Internal Medicine "E" Department, Tel Aviv Sourasky University Medical Center, Tel Aviv 6423906, Israel.

ORCID-Profile: Saar Beit Yaakov, Tomer Ziv Baran

Förderung

  • Dalya & Arye Prashkovsky grant for medical research
  • Dalya & Arye Prashkovsky

Zitieren

APA

Beit Yaakov, S., Argov, O., Rogowski, O., Klechevski, C., Perlman, S., Shtark, M., Ziv Baran, T., Berliner, S., & Wasserman, A. (2026). Normoferritinemic Versus Hyperferritinemic Inflammation in Patients Admitted to the Department of Internal Medicine. Journal of Clinical Medicine, 15(7), 2646. https://doi.org/10.3390/jcm15072646

Vancouver

Beit Yaakov S, Argov O, Rogowski O, Klechevski C, Perlman S, Shtark M, et al. Normoferritinemic Versus Hyperferritinemic Inflammation in Patients Admitted to the Department of Internal Medicine. Journal of Clinical Medicine. 2026;15(7):2646. doi:10.3390/jcm15072646

BibTeX
@article{BeitYaakov2026,
  author = {Beit Yaakov, Saar and Argov, Ori and Rogowski, Ori and Klechevski, Chen and Perlman, Saritte and Shtark, Moshe and Ziv Baran, Tomer and Berliner, Shlomo and Wasserman, Asaf},
  title = {Normoferritinemic Versus Hyperferritinemic Inflammation in Patients Admitted to the Department of Internal Medicine},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {7},
  pages = {2646},
  doi = {10.3390/jcm15072646}
}
Kostenlos starten →